• About us
• Contact

Advertisement

Organisation › Details

NMI TT Pharmaservices Berlin

NMI TT Pharmaservices is a preclinical Contract Research Organisation dedicated to provide integrated experts services to customers in pharma, biotech, medtech, and academia. The company’s business is focused on high-quality services and R&D support for drug discovery and development, with a strong track record and a broad portfolio of offerings in the areas of biochemistry, protein profiling, molecular biology, and safety pharmacology. NMI TT GmbH, founded in 2002, is a spin-out of the Natural and Medical Sciences Institute (NMI) at the University of Tübingen, with its headquarters in Reutlingen and, since 2015, with a new branch in Berlin, Germany. *

 

	Start	2015-09-01 established
	Group	University of Tübingen (Eberhard-Karls-Universität)
	Industry	contract research (drugs)
	Industry 2	preclinical research
	Person	Sachse, Christoph (Univ Tübingen 201504– Site Head Berlin NMI TT Pharmaservices before siTools + Cenix BioScience)
	Person 2	Hämmerle, Hugo (Univ Tübingen 201204 Prof + Head of NMI)
	Region	Berlin
	Country	Germany
	Street	178 Müllerstr. c/o Bayer CoLaborator (Gebäude S141)
	City	13353 Berlin
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-12-30

Advertisement

More documents for University of Tübingen (Eberhard-Karls-Universität)

• [1] Boehringer Ingelheim. (10/20/22). "Press Release: University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs". Tübingen & Ingelheim....
• [2] SHS Gesellschaft für Beteiligungsmanagement mbH. (8/18/22). "Press Release: SHS Appoints Manfred Ulmer-Weber to the Management Board". Tübingen....
• [3] Corat Therapeutics GmbH. (6/22/21). "Press Release: CORAT Antibody COR-101 Binds and Inhibits all B.1.617 SARS-CoV-2 Variants, Including the Fast Proliferating “delta” Variant". Braunschweig....
• [4] Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich....
• [5] NMI TT Pharmaservices. (8/6/19). "Press Release: LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development". Lincoln, NE....
• [6] ERS Genomics Ltd.. (5/31/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices". Dublin & Reutlingen....
• [7] NMI TT Pharmaservices. (9/11/17). "Press Release: NMI TT Takes Over Global Zeptosens RPPA Chip Supply". Reutlingen & Berlin....
• [8] NMI TT Pharmaservices. (6/22/17). "Press Release: NMI TT Pharmaservices and Charité Awarded Grant for Development of Protein Profiling for Individualization of Tumor Therapy". Berlin....
• [9] Bruker Corporation. (6/1/17). "Press Release: Bruker Introduces New Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control at the ASM Microbe 2017 Meeting". New Orleans, LA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.